At a glance
- Originator Ceridia
- Class Antineoplastics; Camptothecins; Indolizines; Pyrans; Quinolines; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 21 Sep 2023 Discontinued - Preclinical for Cancer in Australia (PO)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Cancer in Australia (PO)
- 16 Aug 2016 Chemical structure information added